Food
Pharma Spends More but Approvals Decline in 2005 1/26/06
January 26, 2006 8:48 am | Articles | CommentsSource: New York Times
FDA Simplifies Earliest Clinical Studies 1/17/06
January 17, 2006 7:38 am | Articles | CommentsReleases guidance for “phase 0” trials
FDA Announces NCTR Interim Chief 1/9/06
January 10, 2006 5:51 am | Articles | CommentsSlikker will lead toxicology program
Quantitative HPLC Analysis of Lipids
January 9, 2006 9:46 am | Articles | CommentsSeparation of nonpolar lipid class standards using a normal-phase HPLC
Focus on Clinical 1/6/06
January 6, 2006 9:39 am | Articles | CommentsListing of drug developments and approvals
Focus on Clinical 12/9/05
December 8, 2005 11:04 am | Articles | CommentsListing of drug developments and approvals
Software Automates Genotoxicity Screening 11/29/05
November 29, 2005 10:22 am | Articles | CommentsImage analysis tool from GE
Biomarkers: Biologists’ Best Friends
November 8, 2005 7:25 am | Articles | CommentsChondroGene laboratory technologist extracting RNA from whole blood samples. The RNA extracted from these samples is used in the development and testing of the company's blood-based colon cancer test.
Identifying Liver Toxicity Biomarkers 11/7/05
November 7, 2005 9:26 am | Articles | CommentsFDA, industry to collaborate
Focus on Clinical 11/4/05
November 4, 2005 5:18 am | Articles | CommentsListing of drug developments and approvals
GSK Drug for Rare Leukemia and Lymphoma Approved 11/1/05
November 1, 2005 10:41 am | Articles | CommentsOrphan drug meets accelerated approval
Cancer Drug Could Treat Dementia 10/31/05
November 1, 2005 4:37 am | Articles | CommentsEnhances long-term memory
FDA Awards Drug-Monitoring Contracts 10/17/05
October 17, 2005 7:02 am | Articles | CommentsMore control with new mechanism
Microfluidic Analyzers: Slow, Steady Progress
October 11, 2005 10:37 am | Articles | CommentsFigure 1. Center for Microfluidics and Medical Diagnostics Director Dr. Chia Chang (right) and Center research professor Dr. Zilin Chen have developed high-pressure, low power pumps for controlled drug delivery through the skin.
Focus on Clinical 10/7/05
October 6, 2005 12:29 pm | Articles | CommentsListing of drug developments and approvals
FDA Panel Recommends Inhaled Insulin 9/12/05
September 12, 2005 7:30 am | Articles | CommentsA U.S. Food and Drug Administration (FDA) advisory committee voted 7-2 to recommend the approval of Pfizer’s, New York, Exubera, the long-anticipated inhaled insulin product for treatment of Type 1 and Type 2 diabetes.
Focus on Clinical 9/9/05
September 9, 2005 8:08 am | Articles | CommentsListing of drug developments and approvals
Dual Access Laminar Flow Cabinet
September 7, 2005 6:59 am | Articles | CommentsPuriCare Dual Access Laminar Flow Cabinet is designed for permanent installation through an opening in the wall between a vivarium "clean" room and "dirty" room that is exposed to dust and other particles present in the lab environment. It provides Class 100 clean air in the work area.
FDA Says Collaboration Key to Drug Development 8/17/05
August 17, 2005 10:49 am | Articles | CommentsNew report addresses high drug candidate failure rate
Focus on Clinical 8/12/05
August 12, 2005 7:59 am | Articles | CommentsListing of drug developments and approvals
Discovering the Signs for Iressa Failure 8/10/05
August 10, 2005 10:32 am | Articles | CommentsBiomarker of drug resistance found in patients
Evaluating Gene Expression Biomarker Assays 7/14/05
July 14, 2005 11:46 am | Articles | CommentsMeeting the FDA standards for biomarker data
New MALDI TOF/TOF Promises 10X Sensitivity 6/7/05
June 7, 2005 12:41 pm | Articles | CommentsResearchers anticipate entry into biomarker discovery
Weekly News Roundup 5/13/05
May 16, 2005 8:22 am | Articles | CommentsNIH finds Software for High-Throughput Screening
Sequencing In The Post Genomic Age
April 12, 2005 10:39 am | Articles | CommentsPronouncements of the “post genomic age” notwithstanding, genome sequencing is as relevant today as before the Human Genome Project began seventeen years and $2.7 billion ago. If the promise of genomics is ever to be realized, then clearly the most challenging sequencing work lies.
